Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995–2004)

被引：0
|
作者：
Yiqun Chen
Zhenguo Qiu
Anmmd Kamruzzaman
Tom Snodgrass
Andrew Scarfe
Heather E. Bryant
机构：
[1] Cancer Institute New South Wales,Cancer Information and Registries Division
[2] Alberta Cancer Board,Division of Population Health and Information
[3] Alberta Cancer Board,Cross Cancer Institute
[4] Canadian Partnership Against Cancer,undefined
来源：
Supportive Care in Cancer | 2010年 / 18卷
关键词：
Metastatic colorectal cancer; Chemotherapy; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：217 / 224
页数：7
相关论文
共 50 条
  • [1] Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995-2004)
    Chen, Yiqun
    Qiu, Zhenguo
    Kamruzzaman, Anmmd
    Snodgrass, Tom
    Scarfe, Andrew
    Bryant, Heather E.
    SUPPORTIVE CARE IN CANCER, 2010, 18 (02) : 217 - 224
  • [2] Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy
    Moisuc, Diana Cornelia
    Constantinescu, Daniela
    Marinca, Mihai Vasile
    Gafton, Bogdan
    Pavel-Tanasa, Mariana
    Cianga, Petru
    CANCERS, 2024, 16 (02)
  • [3] Metastatic colorectal cancer treated by chemotherapy: trends in survival in two patient cohorts treated in 1992-1999 and 2004-2007
    Guillermet, A.
    Montella, A.
    Valenti, A.
    De La Fouchardiere, C.
    Perol, D.
    Favier, B.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 439 - 440
  • [4] Tumor calcification is associated with better survival in metastatic colorectal cancer patients treated with bevacizumab plus chemotherapy
    Zhou, Yu-Wen
    Long, Yi-Xiu
    Liu, Xia
    Liu, Ji-Yan
    Qiu, Meng
    FUTURE ONCOLOGY, 2022, 18 (22) : 2453 - 2464
  • [5] Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver
    Baidoun, Firas
    Merjaneh, Zahi
    Nanah, Rama
    Saad, Anas M.
    Abdel-Rahman, Omar
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (13) : 935 - 951
  • [6] Long term survival in metastatic colorectal cancer treated with leucovorin and 5-fluoro-uracil chemotherapy
    Perez, N
    Tournigand, C
    Mabro, M
    Molitor, JL
    Artru, P
    Carola, E
    André, T
    Louvet, C
    Krulik, M
    de Gramont, A
    REVUE DE MEDECINE INTERNE, 2004, 25 (02): : 124 - 128
  • [7] The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy
    Suzuki, C.
    Blomqvist, L.
    Sundin, A.
    Jacobsson, H.
    Bystrom, P.
    Berglund, A.
    Nygren, P.
    Glimelius, B.
    ANNALS OF ONCOLOGY, 2012, 23 (04) : 948 - U7
  • [8] Prolonged survival in metastatic colorectal cancer following chemotherapy
    Paul, Doru
    Gold, Menachem
    Nouraddin, Nouraddin
    CLINICAL CASE REPORTS, 2014, 2 (05): : 219 - 223
  • [9] Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice
    Rossi, Luigi
    Veltri, Enzo
    Zullo, Angelo
    Zoratto, Federica
    Colonna, Maria
    Di Seri, Marisa
    Longo, Flavia
    Mottolese, Marcella
    Giannarelli, Diana
    Ruco, Luigi
    Romiti, Adriana
    Barucca, Viola
    Adua, Daniela
    Tomao, Silverio
    FUTURE ONCOLOGY, 2012, 8 (09) : 1193 - 1197
  • [10] Association between sidedness and survival among chemotherapy refractory metastatic colorectal cancer patients treated with trifluridine/tipiracil or regorafenib
    Hsiao, Kai-Yuan
    Chen, Hsin-Pao
    Rau, Kun-Ming
    Liu, Kuang-Wen
    Shia, Ben-Chang
    Chang, Wei-Shan
    Liang, Hao-Yun
    Hsieh, Meng-Che
    ONCOLOGIST, 2024, 29 (12) : e1669 - e1679
12345